Literature DB >> 2157816

Reduction of muscarinic receptor density and of guanine nucleotide-stimulated phosphoinositide hydrolysis in human SH-SY5Y neuroblastoma cells following long-term treatment with 12-O-tetradecanoylphorbol 13-acetate or mezerein.

C L Cioffi1, S K Fisher.   

Abstract

The actions of tumor promoters on the coupling of muscarinic receptors to the hydrolysis of inositol lipids and the generation of Ca2+ signals were examined in the human neuroblastoma SH-SY5Y cell line. Pretreatment of SH-SY5Y cells with 50 nM 12-O-tetradecanoylphorbol 13-acetate (TPA) for 5 days resulted in neuronal differentiation, a 28% decrease in both N-[3H]methylscopolamine and [3H]-scopolamine binding, and a significantly larger reduction (48%) in agonist-stimulated 3H-inositol phosphate generation. Whereas mezerein could mimic the effects produced by TPA, the biologically inactive 4 alpha-phorbol 12,13-didecanoate was without effect on both antagonist binding and agonist-stimulated phosphoinositide (PPI) turnover. A decline (approximately 50%) in the agonist-mediated rise in cytoplasmic Ca2+ and a substantial loss of protein kinase C activity also were observed following pretreatment with TPA or mezerein. The ability of fluoride, an agent capable of direct activation of guanine nucleotide binding proteins, to stimulate 3H-inositol phosphate release was significantly reduced in SH-SY5Y cells treated with these agents. Furthermore, pretreatment of SH-SY5Y neuroblastoma cells with TPA or mezerein impaired 3H-inositol phosphate formation induced by the addition of either guanosine 5'-O-(3-thiotriphosphate) or carbamylcholine to digitonin-permeabilized cells, but not that elicited by the addition of 2 mM CaCl2. Although cells cultured in the presence of serum-free media also exhibited neuronal differentiation, no significant alteration in either muscarinic receptor number or agonist-stimulated PPI hydrolysis was observed. The results suggest that TPA and mezerein decrease agonist-stimulated PPI hydrolysis and Ca2+ signaling in SH-SY5Y cells not only by a reduction in muscarinic receptor number but also through an inhibition of guanine nucleotide-stimulated PPI turnover.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157816     DOI: 10.1111/j.1471-4159.1990.tb01227.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  SK & F 96365 inhibits carbachol-induced phosphoinositide turnover in human neuroblastoma SH-SY5Y and rat cerebellar granule cells.

Authors:  W W Lin; C W Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

2.  Routes of delivery of muscarinic acetylcholine receptors to the plasma membrane in NG108-15 cells.

Authors:  J A Koenig; J M Edwardson
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

3.  A rapid attenuation of muscarinic agonist stimulated phosphoinositide hydrolysis precedes receptor sequestration in human SH-SY-5Y neuroblastoma cells.

Authors:  S K Fisher; D M Slowiejko; E L McEwen
Journal:  Neurochem Res       Date:  1994-05       Impact factor: 3.996

4.  Down-regulation of brain muscarinic cholinergic receptor promoted by diacylglycerols and phorbol ester.

Authors:  M F Pediconi; F J Barrantes
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

5.  Contrasting effects of phorbol ester and agonist-mediated activation of protein kinase C on phosphoinositide and Ca2+ signalling in a human neuroblastoma.

Authors:  G B Willars; R A Challiss; J A Stuart; S R Nahorski
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

6.  Complex relationship between Ins(1,4,5)P3 accumulation and Ca2+ -signalling in a human neuroblastoma reveled by cellular differentiation.

Authors:  A K Martin; S R Nahorski; G B Willars
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

7.  Muscarinic receptor stimulation of D-aspartate uptake into human SH-SY5Y neuroblastoma cells is attenuated by hypoosmolarity.

Authors:  Daniel J Foster; Anne M Heacock; Stephen K Fisher
Journal:  J Pharmacol Exp Ther       Date:  2010-01-15       Impact factor: 4.030

8.  Muscarinic (M1) receptor-mediated inhibition of K(+)-evoked [3H]-noradrenaline release from human neuroblastoma (SH-SY5Y) cells via inhibition of L- and N-type Ca2+ channels.

Authors:  R L McDonald; P F Vaughan; C Peers
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

9.  Regulation of cyclic AMP response-element binding-protein (CREB) by Gq/11-protein-coupled receptors in human SH-SY5Y neuroblastoma cells.

Authors:  Elizabeth M Rosethorne; Stefan R Nahorski; R A John Challiss
Journal:  Biochem Pharmacol       Date:  2007-10-22       Impact factor: 5.858

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.